KCNN4 and neoplasm: Our study provides evidence that fractionated tumor irradiation combined with systemic application of the KCa3.1 blocker TRAM-34 prolongs the survival of VM/Dk mice with orthotopically transplanted syngeneic SMA-560 cells.